<DOC>
	<DOCNO>NCT02827916</DOCNO>
	<brief_summary>Oxaliplatin anticancer agent commonly use treatment colorectal cancer . However , development neuropathic pain treatment limit use . These manifest acute hyperesthesia / distal cold allodynia chronic course hypoesthesia . It widely report pain consecutive hyperexcitability ioniques2 channel ( mainly sodium potassium channel ) . However , pathophysiological mechanism neurotoxicity multifactorial still imperfectly describe . Since May 2014 , hospital group Paris Saint Joseph lead pilot study LIPIDOXA whose challenge quantify / measure NAION explain biochemical approach , specifically Lipidomics . The CANALOXA study logical continuation LIPIDOXA study insofar design methodology relies heavily technique develop LIPIDOXA study expect result complementary LIPIDOXA .</brief_summary>
	<brief_title>Exploration Neuropathic Pain Induced Oxaliplatin Electrophysiological Approach</brief_title>
	<detailed_description>Main objective : , cancer patient chronically treat oxaliplatin ( 5 course ) exhibit sign neuropathy , correlate quantitative change thermal sensitivity hot cold ( Thermotest , Quantitative Sensory Testing QST ) change ion conductance chlorine measure electrophysiological technique ( SUDOSCAN ) . Secondary objective : - Correlating result obtain type technique descriptive parameter population include . - Understand importance regulating activity chloride channel development neuropathy induce oxaliplatin . Methodology : Prospective study , single center , intervention routine care . Time study : February 2015 - October 2016 1 . Evaluation neuropathy electrophysiological method ( SUDOSCAN ) The SUDOSCAN new technology fast non-invasive quantify degree neuropathy objectively evaluation chloride conductance skin palm sol pieds4,5 . 2 . Evaluation neuropathy device quantitative measurement neuropathic pain The pain symptom evaluate various semi-objective neuropathy quantification tool ( Quantitative Sensory Testing device ) 6 : - The Thermotest ( Somedic® ) : medical device measure thermal sensitivity threshold cold hot : cold sensitivity threshold , threshold sensitivity hot , cold pain threshold , pain threshold warm . These stimulus transmit fiber Adelta C. Since dysesthesia thermal stimulus ( allodynia acute chronical hypoesthesia ) typical oxaliplatin , Thermotest fundamental . - Questionnaire NPSI ( Neuropathic Pain Symptom Inventory ) widely use field validate . 3 . Statistical Analysis : Professor Gilles Chatellier , statistician ( Clinical Research Unit , Hôpital Européen Georges Pompidou ) bring expertise statistical analysis . NB : For subject award identifier ( simple counter : increment measurement inclusion ) data enter computer file send statistician charge analysis . There exchange personal data study single center site GHPSJ . Development study : - Inclusion patient treat oxaliplatin 6th cycle ( FOLFOX protocols FOLFIRINOX , EOX , GEMOX , EOF , XELOX ) . - Expected duration patient recruitment : 9 month - Number patient recruit duration participation patient : Based 75 patient see 9 month GHSPJ oncology department cancer digestive tract , know prevalence neuropathic pain oxaliplatin 50-70 % ( Attal 2009 ) , investigator plan include least 36 patient period 9 month .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patient newly treat oxaliplatin Patient suffer type cancer treat oxaliplatin Man Woman 18 Patient brain leptomeningeal metastases Patient previously treat cisplatin Patient addict alcohol Diabetic patient peripheral neurological disorder Patient receive calcium magnesium salt intravenously Patient suffer peripheral neuropathy Patient suffer psychiatric disorder Patient treat least one follow drug : venlafaxine , carbamazepine , gabapentin , pregabalin , clomipramine , amitriptyline , imipramine , duloxetine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>